virus
associ
frequent
common
cold
rhinovirus
coronavirus
first
prospect
cohort
studi
determin
preval
rhinoviru
coronaviru
infect
patient
age
hospit
acut
respiratori
ill
describ
hospit
admiss
acut
respiratori
ill
identifi
cell
cultur
rhinoviru
serolog
assay
pair
sera
coronavirus
perform
total
infect
rhinovirus
coronavirus
identifi
respiratori
ill
addit
addit
infect
associ
respiratori
virus
identifi
infect
rhinoviru
coronaviru
underli
cardiopulmonari
diseas
present
patient
age
year
age
year
age
year
predomin
clinic
syndrom
vari
age
pneumonia
bronchiol
children
age
year
exacerb
asthma
older
children
young
adult
pneumonia
exacerb
chronic
obstruct
pulmonari
diseas
congest
heart
failur
older
adult
therefor
rhinoviru
coronaviru
infect
hospit
patient
associ
lower
respiratori
tract
ill
age
group
virus
associ
frequent
common
cold
rhinovirus
coronavirus
first
prospect
cohort
studi
determin
preval
rhinoviru
coronaviru
infect
patient
age
hospit
acut
respiratori
ill
describ
hospit
admiss
acut
respiratori
ill
identifi
cell
cultur
rhinoviru
serolog
assay
pair
sera
coronavirus
perform
total
infect
rhinovirus
coronavirus
identifi
respiratori
ill
addit
addit
infect
associ
respiratori
virus
identifi
infect
rhinoviru
coronaviru
underli
cardiopulmonari
diseas
present
patient
age
year
age
year
age
year
predomin
clinic
syndrom
vari
age
pneumonia
bronchiol
children
age
year
exacerb
asthma
older
children
young
adult
pneumonia
exacerb
chronic
obstruct
pulmonari
diseas
congest
heart
failur
older
adult
therefor
rhinoviru
coronaviru
infect
hospit
patient
associ
lower
respiratori
tract
ill
age
group
rhinovirus
coronavirus
frequent
identifi
caus
common
cold
syndrom
rhinovirus
member
picornavirida
famili
first
identifi
sinc
differ
serotyp
identifi
human
coronavirus
member
coronavirida
famili
first
identifi
particularli
difficult
isol
use
standard
cell
cultur
techniqu
selflimit
upper
respiratori
tract
ill
common
cold
syndrom
usual
clinic
manifest
infect
virus
howev
past
decad
sever
studi
found
virus
associ
clinic
syndrom
requir
hospit
care
recent
perform
prospect
cohort
studi
evalu
associ
respiratori
viru
infect
respiratori
condit
identifi
hospit
patient
articl
describ
demograph
clinic
characterist
hospit
patient
identifi
recent
rhinoviru
coronaviru
infect
studi
design
prospect
studi
conduct
urban
public
teach
hospit
ben
taub
gener
hospit
children
hospit
texa
children
hospit
commun
hospit
st
luke
episcop
hospit
houston
texa
patient
admit
diagnosi
suggest
acut
respiratori
condit
congest
heart
failur
chf
visit
hospit
confirm
elig
seek
consent
particip
acut
respiratori
diseas
diagnos
includ
follow
pneumonia
tracheobronch
bronchiti
croup
exacerb
asthma
chronic
obstruct
pulmonari
diseas
copd
patient
activ
tuberculosi
known
hiv
diseas
exclud
admiss
hospit
nasal
andor
throat
swab
acut
serum
specimen
obtain
convalesc
serum
collect
day
obtain
acut
serum
patient
inpati
medic
record
review
inform
collect
includ
sociodemograph
data
symptom
sign
acut
respiratori
diagnosi
diagnos
locat
admiss
ie
gener
ward
intens
care
unit
durat
hospit
need
ventilatori
support
chest
radiograph
interpret
laboratori
method
respiratori
secret
specimen
inocul
cell
cultur
line
includ
human
embryon
lung
fibroblast
cell
continu
human
epithelioid
carcinoma
cell
rhesu
monkey
kidney
cell
primari
rhesu
monkey
kidney
madindarbi
canin
kidney
mdck
cell
rhinovirus
identifi
initi
characterist
cytopath
chang
induc
cell
cultur
rhinovirus
differenti
enterovirus
use
acid
labil
revers
transcriptas
rt
pcr
assay
coronaviru
infect
identifi
serolog
use
pair
serum
sampl
convalesc
serum
collect
least
day
acut
serum
collect
antibodi
test
coronaviru
perform
use
microneutr
assay
infect
defin
presenc
increas
antibodi
level
elisa
use
measur
antibodi
coronaviru
infect
defin
increas
elisa
igg
antibodi
increas
confirm
repeat
test
coinfect
respiratori
virus
identifi
cell
cultur
serolog
describ
elsewher
total
patient
enrol
studi
patient
ill
evalu
ill
pair
sera
avail
test
coronaviru
infect
sixtyon
ill
identifi
associ
rhinoviru
coronaviru
infect
infect
respiratori
virus
tabl
addit
ill
associ
common
cold
viru
rhinovirus
coronaviru
addit
respiratori
viru
influenza
viru
respiratori
syncyti
viru
rsv
parainfluenza
viru
patient
dual
viru
infect
tend
younger
age
year
like
pair
sera
collect
versu
respect
group
identifi
common
cold
viru
infect
ill
consid
potenti
confound
effect
addit
respiratori
viru
infect
racialethn
distribut
patient
common
cold
viru
infect
similar
overal
studi
popul
versu
black
vern
p
n
p
su
hispan
versu
white
n
p
versu
asian
addit
age
distribut
n
p
patient
rhinoviru
coronaviru
infect
similar
overal
studi
popul
versu
age
year
versu
age
year
versu
age
year
eighteen
patient
age
ill
associ
common
cold
virus
occur
throughout
year
less
frequent
summer
month
distribut
ill
follow
case
occur
januari
march
april
june
juli
septemb
octob
decemb
fiftyeight
percent
rhinoviru
infect
coronaviru
infect
occur
octob
march
infect
associ
respiratori
virus
also
occur
period
patient
admit
diagnos
tabul
tabl
group
age
year
common
clinic
diagnos
admiss
asthma
bronchiol
possibl
n
p
sepsi
pneumonia
patient
age
year
primari
reason
admiss
treatment
asthma
patient
pneumonia
patient
age
year
clinic
diagnos
admiss
treatment
pneumonia
chf
copd
n
p
asthma
overal
chronic
cardiopulmonari
diseas
diagnosi
present
patient
asthma
common
ill
follow
chf
copd
hospit
care
took
place
ward
case
howev
case
treat
intens
care
unit
intermedi
care
unit
one
patient
age
year
requir
mechan
ventil
compar
patient
age
year
tabl
fever
elev
wbc
count
common
patient
age
year
wheez
seen
age
group
two
cultur
blood
obtain
patient
age
year
posit
staphylococcu
speci
probabl
contamin
two
cultur
blood
obtain
patient
age
year
pneumonia
posit
streptococcu
pneumonia
antibiot
prescrib
major
patient
patient
surviv
mean
median
length
stay
day
patient
age
year
day
patient
age
year
day
patient
age
year
chang
seen
chest
radiograph
larg
reflect
clinic
diagnos
patient
age
year
abnorm
report
patient
infiltr
pneumonia
hyperinfl
atelectasi
abnorm
seen
patient
age
year
hyper
inflat
infiltr
abnorm
detect
patient
age
year
pneumonia
chf
cardiomegali
emphysemat
chang
pulmonari
nodul
rhinovirus
coronavirus
usual
recogn
caus
upper
respiratori
ill
mostli
benign
selflimit
howev
common
cold
virus
also
associ
ill
requir
hospit
previou
report
role
one
virus
evalu
select
popul
basi
age
underli
diseas
studi
first
analyz
clinic
characterist
patient
age
group
admit
acut
respiratori
diseas
infect
rhinoviru
coronaviru
found
distribut
present
vari
age
underli
diseas
patient
patient
age
year
underli
chronic
pulmonari
diseas
asthma
contrast
patient
age
year
asthma
patient
age
year
asthma
copd
chf
bronchiol
pneumonia
common
clinic
syndrom
associ
rhinoviru
infect
hospit
children
age
year
find
confirm
studi
rsv
frequent
identifi
respiratori
viru
young
children
hospit
acut
respiratori
condit
studi
rhinoviru
second
common
clinic
present
rhinoviru
infect
may
similar
rsv
addit
coronaviru
infect
associ
lower
respiratori
tract
ill
includ
pneumonia
bronchiol
children
age
year
less
inform
avail
regard
rel
import
coronaviru
infect
age
group
identifi
coronaviru
infect
patient
age
year
although
pair
sera
avail
patient
age
group
associ
respiratori
viru
infect
exacerb
asthma
recogn
sever
decad
last
sever
year
respiratori
viru
infect
identifi
wheez
episod
schoolag
children
wheez
episod
adult
virusassoci
exacerb
sever
enough
requir
hospit
correl
hospit
asthma
season
preval
upper
respiratori
viru
infect
note
especi
children
sever
studi
rhinoviru
common
respiratori
viru
associ
asthma
exacerb
coronaviru
second
frequent
current
studi
princip
reason
hospit
older
children
young
adult
rhinoviru
coronaviru
infect
asthma
exacerb
respiratori
viru
infect
also
associ
worsen
chronic
diseas
includ
cardiopulmonari
disord
copd
chf
although
proport
exacerb
diseas
associ
respiratori
viru
exacerb
lower
seen
asthma
burden
infect
substanti
greater
chronic
ill
patient
healthi
subject
similar
age
current
studi
mani
patient
age
year
underli
lung
diseas
chf
addit
sever
patient
admit
pneumonia
unclear
whether
rhinoviru
caus
pneumonia
recov
lower
respiratori
tract
infect
individu
increas
number
inflammatori
cell
bronchial
mucosa
note
experiment
infect
upper
respiratori
tract
possibl
virus
might
associ
increas
risk
bacteri
pneumonia
similar
describ
influenza
suggest
identif
least
pneumonia
ill
oldest
age
group
associ
concomit
pneumonia
infect
howev
studi
design
delin
virusbacteria
interact
sever
potenti
shortcom
current
studi
pair
sera
avail
subset
popul
thu
substanti
potenti
introduct
bia
identifi
rel
import
coronaviru
infect
popul
hand
infect
addit
respiratori
virus
influenza
viru
rsv
may
miss
person
serolog
studi
perform
anoth
potenti
shortcom
control
popul
includ
studi
therefor
frequenc
rhinoviru
coronaviru
infect
ambulatori
popul
popul
hospit
nonrespiratori
condit
asymptomat
popul
determin
howev
studi
virolog
studi
perform
laboratori
period
cultur
posit
respiratori
viru
asymptomat
adult
serolog
studi
identifi
respiratori
viru
infect
asymptomat
period
use
rtpcr
assay
rhinoviru
coronaviru
increas
frequenc
viru
infect
identifi
compar
cell
cultur
serolog
method
previou
studi
asthmat
patient
assay
perform
current
studi
therefor
burden
infect
detect
studi
like
minim
estim
infect
frequenc
morbid
associ
rhinoviru
coronaviru
infect
especi
highrisk
popul
patient
chronic
lung
diseas
suggest
infect
target
prevent
treatment
strategi
develop
convent
vaccin
rhinoviru
hamper
exist
differ
serotyp
lack
protect
associ
experiment
parenter
vaccin
less
known
number
coronaviru
serotyp
experiment
human
vaccin
evalu
ifna
antivir
agent
effect
experiment
rhinoviru
coronaviru
infect
also
use
effect
postexposur
prophylaxi
natur
cold
util
ifna
normal
healthi
popul
limit
local
nasal
toxic
singl
studi
evalu
efficaci
prevent
respiratori
viru
infect
result
complic
patient
chronic
lung
diseas
benefici
effect
ifna
seen
popul
patient
asthma
copd
howev
studi
insuffici
power
demonstr
effect
caus
prevent
rhinoviru
coronaviru
infect
newer
antirhinoviru
drug
tremacamra
pleconaril
recent
shown
benefici
effect
treatment
experiment
rhinoviru
infect
suggest
may
role
drug
highrisk
popul
morbid
associ
rhinoviru
coronaviru
infect
highrisk
patient
group
target
futur
evalu
antivir
chemotherapi
strategi
